MYX mayne pharma group limited

Ann: Notice under ASX Listing Rule 3.10A, page-23

  1. 382 Posts.
    lightbulb Created with Sketch. 231

    I can read fine. The issue appears to be your inability to consider anyone else's opinion but your own.

    Profit is up you say? MYX haven't seen a net profit in years.
    You say it's the genius management of MYX turning the company around.
    I say it's more a case of when you hit rock bottom things can only improve.
    They had to do something while the generics division kept getting decimated and they've naturally increased the focus on the other divisions. That's hardly a revolutionary strategy.
    MYX's big strategic moves have been Nuvaring generic which has gone nowhere and now Nextstellis of which we're all hopeful but we've heard nothing since the half year results in Feb. Nextstellis was certainly too early in it's life to have had any positive impact on the last set of results.
    As I said in my previous post, according to my 'reading' and calculations, the write offs from the Teva purchase should be finished which means that I'm hopeful of finally seeing a Net Profit in the next set of results.

    I say what I post is my own opinions and analysis
    You say it's whinging
    tomato potato IDGAF
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.00
Change
0.080(1.63%)
Mkt cap ! $406.2M
Open High Low Value Volume
$4.93 $5.10 $4.93 $3.062M 610.2K

Buyers (Bids)

No. Vol. Price($)
2 67102 $5.00
 

Sellers (Offers)

Price($) Vol. No.
$5.05 5000 1
View Market Depth
Last trade - 16.10pm 24/06/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.